Neurotrope Announces Top-line Results From Confirmatory Phase 2 Study of Bryostatin-1 in Moderate to Severe Alzheimer's Disease

Stock Information for Neurotrope Inc.

Loading

Please wait while we load your information from QuoteMedia.